REPO4EU

The AI engine Fit Assessment

Beta

REPO4EU effectively leverages machine learning for drug repurposing, discovering new patterns in disease mechanisms, and expanding therapeutic options.

Blurb

REPO4EU’s ultimate goal is to host & grow a EU industry-level online platform for validated precision drug repurposing with a global reach.

HQ Location

United States

Founded

2022

Employees

11 - 50

Total funding raised

Not available

Last Funding Event

Not available

Smart insights

  • Catherine Msc (Chief People Officer) worked at Lilium as Head of People Business Partnering for 1.5 years (2021 - 2022)
  • Val Miftakhov (Founder & CEO) worked at Google in various roles, including Head of R&D, Google for Work Incubation, for a total of 4 years (2012 - 2016)
  • 6m headcount growth: 25%
  • 1Y headcount growth: 94%
  • Headcount-to-last-round ratio: 5.3 employees/$M
Subspaces
  • Drug Repurposing

REPO4EU is the Euro/Global Platform for Drug Repurposing - from imprecise drug therapy to AI-powered precision medicine.

Should you need any help in searching for bioinformatics support for an unmet medical need, a registered compound or a specific mechanism; exploring your freedom to operate or a patenting strategy or regulatory advice; liaising with a business partner, setting up a clinical trial test site for phase I-III or crafting a business plan... we have the experts and global experience to help and work with you!